January 30, 2023
Pharmabiz
US FDA approves Keytruda as adjuvant treatment following surgical resection and platinumbased chemotherapy for patients with stage IB (T2a =4 centimeters), II, or IIIA NSCLC
Merck, known as MSD outside of the United States and Canada, announced today that the US Food and Dru... See more »
